Key facts
- This page summarizes Mitchell Gold's Form 4 filing for Attovia Therapeutics, Inc. (ATTO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 06 Aug 2026, 17:17.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates.